Qiagen NV (QGEN)
43.23
-0.82
(-1.86%)
USD |
NYSE |
Nov 12, 16:00
43.24
0.00 (0.00%)
After-Hours: 20:00
Qiagen Price: 43.23 for Nov. 12, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 12, 2024 | 43.88 | 43.99 | 43.23 | 43.23 | 852246.0 |
Nov 11, 2024 | 43.79 | 44.09 | 43.54 | 44.05 | 977204.0 |
Nov 08, 2024 | 44.22 | 44.27 | 43.63 | 43.76 | 805716.0 |
Nov 07, 2024 | 45.19 | 45.35 | 43.83 | 44.15 | 1.451M |
Nov 06, 2024 | 43.02 | 44.06 | 42.71 | 43.87 | 1.601M |
Nov 05, 2024 | 43.69 | 44.07 | 43.45 | 43.95 | 869581.0 |
Nov 04, 2024 | 43.56 | 43.86 | 43.45 | 43.65 | 1.257M |
Nov 01, 2024 | 42.88 | 43.22 | 42.73 | 43.08 | 873496.0 |
Oct 31, 2024 | 42.06 | 42.39 | 41.89 | 42.10 | 925569.0 |
Oct 30, 2024 | 42.02 | 42.47 | 41.92 | 42.24 | 928685.0 |
Oct 29, 2024 | 41.66 | 42.04 | 41.58 | 41.83 | 476024.0 |
Oct 28, 2024 | 42.08 | 42.17 | 41.74 | 41.80 | 615925.0 |
Oct 25, 2024 | 41.70 | 42.00 | 41.51 | 41.55 | 492400.0 |
Oct 24, 2024 | 42.23 | 42.29 | 41.58 | 41.60 | 567391.0 |
Oct 23, 2024 | 42.21 | 42.26 | 41.93 | 42.12 | 489589.0 |
Oct 22, 2024 | 42.07 | 42.40 | 41.79 | 42.21 | 759736.0 |
Oct 21, 2024 | 42.64 | 42.65 | 41.87 | 42.12 | 588995.0 |
Oct 18, 2024 | 42.81 | 43.00 | 42.63 | 43.00 | 1.022M |
Oct 17, 2024 | 42.40 | 42.93 | 42.27 | 42.69 | 1.660M |
Oct 16, 2024 | 43.84 | 43.88 | 43.13 | 43.21 | 1.541M |
Oct 15, 2024 | 44.09 | 44.61 | 43.78 | 43.88 | 646994.0 |
Oct 14, 2024 | 43.91 | 44.23 | 43.69 | 44.09 | 1.371M |
Oct 11, 2024 | 43.78 | 44.08 | 43.75 | 43.92 | 1.141M |
Oct 10, 2024 | 44.18 | 44.26 | 43.08 | 43.28 | 822481.0 |
Oct 09, 2024 | 43.74 | 44.45 | 43.63 | 44.45 | 1.529M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
33.93
Minimum
Dec 26 2019
58.59
Maximum
Sep 02 2021
47.39
Average
47.25
Median
Mar 23 2023
Price Benchmarks
LENZ Therapeutics Inc | 37.30 |
Oruka Therapeutics Inc | 26.15 |
Boston Scientific Corp | 88.72 |
uniQure NV | 6.705 |
ProQR Therapeutics NV | 3.985 |
Price Related Metrics
PE Ratio | 136.31 |
PS Ratio | 4.991 |
Price to Book Value | 2.821 |
Price to Free Cash Flow | 23.90 |
Earnings Yield | 0.73% |
Market Cap | 9.608B |
Operating PE Ratio | 58.14 |
Normalized PE Ratio | 65.97 |